About 801 results for "nda plus"

TESARO Receives FDA Fast Track Designation for Niraparib and I...

WALTHAM, Mass., Sept. 12, 2016 (GLOBE NEWSWIRE) -- TESARO, Inc. (NASDAQ: TSRO ), an oncology-focused biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to niraparib for the ... Benzinga.com, 2 weeks ago

US FDA grants fast track designation to Tesaro's niraparib - PharmaBiz, 1 week ago

Niraparib Receives FDA Fast Track Designation for the Treatment of Recurrent Platinum-Sensitive Ovarian, Fallopian Tube, or Primary Peritoneal Cancer - ESMO, 1 week ago

More from: USA Life Sciences Database, MoneyAM...and 36 other sources

[x]

Techcircle.in

Govt proposes integration of PAN cards with DigiLock...

In a bid to expand the scope of the DigiLocker project, the National Democratic Alliance (NDA) government will shortly integrate Permanent Account Number (PAN) cards with the system to ensure all commercial transactions and financial services are ...

Techcircle.in, 2 weeks ago

Parsabiv NDA Fails; Implications For Amgen

Introduction With FDA's Complete Response Letter to the NDA for Parsabiv, Amgen (NASDAQ: AMGN ) has been embarrassed again. Yet it trades as if all is OK there. At $172, near its all-time high, it is acting as a safe haven that has been "winnowed ...

Seeking Alpha, 4 weeks ago AMGEN : Provides Update On Status Of Parsabiv(TM) (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA) 4 Traders, 1 month ago Amgen Provides Update On Status Of Parsabiv(TM) (Etelcalcetide) New Drug Application (NDA) Submitted To The U.S. Food And Drug Administration (FDA) Healthcare Sales & Marketing Network, 1 month ago China Food And Drug Administration Accepts NDA For Anticancer Agent Halaven FirstWord Pharma, 1 month ago

More from: International Business Times, PR Newswire...and 12 other sources

[x]

Retrophin: Another Promising Core Plus Biotech Gem

A look at Retrophin's (NASDAQ: RTRX ) stock chart in the past year reveals the "Martin Shkreli discount" is still going strong. Down from $30 and double-bottoming earlier in the year, shares have lightly rebounded to where they trade in the $16 ...

Seeking Alpha, 4 weeks ago

Alkem Labs with sales of Rs.4,992 cr to focus on global markets and R&D

Alkem Laboratories, a Rs. 5,150 crore plus Mumabi based company which entered capital market during December 2015, is moving ahead and establishing its strong presence in the international as well as in domestic markets with a portfolio of 700 ...

PharmaBiz, 1 month ago

Narendra Modi's Independence Day speech: A repeat of NDA's 2-year report card

Prime Minister Narendra Modi's speech, on the country's 70th Independence Day, had all the designs of a smart CEO offering a presentation to his shareholders about the progress made in his term so far and where he intends to take his company (read ...

Firstpost.com, 1 month ago

India.com

NDA government may face dilemma over prosecuting Zakir Naik: Analysts

Mumbai, Aug 14 : The Centre would have to tread cautiously in taking legal action against Islamic preacher Zakir Naik for his alleged hate speeches and involvement in unlawful activities considering his mass appeal and possible fallout in poll-bound ...

India.com, 1 month ago NDA govt may face dilemma over prosecuting Zakir Naik: Analysts Oneindia, 1 month ago Action against Zakir Naik may ruin Modi's poll game Economic Times, 1 month ago Why govt may face dilemma over prosecuting Naik Times of India, 1 month ago

Portola Reports Q2: Focus On AndexXa, Plus The Pipeline

Introduction Junior biotech Portola Pharmaceuticals (NASDAQ: PTLA ) reported earnings after the close Tuesday. More importantly, the company provided updates on its two potentially commercializable products as well as on its cancer drug that is ...

Seeking Alpha, 1 month ago Portola Pharmaceuticals - We're Not Giving Up On This Promising Company Seeking Alpha, 4 weeks ago

Niger Delta Avengers announce conditional ceasefire (PLUS: Their condition)

By News Express on 21/08/2016 Share on Tweet Views: 11 A Nigerian militant group has announced a ceasefire and pledged to support talks with the government, after months of attacks on the country's oil and gas infrastructure that ...

News Express Nigeria, 1 month ago Nigeria Reinstating Payments To Militants - Oil Markets Daily Seeking Alpha, 1 month ago BLOG: Renewed Cash Payments Won't Stop Niger Delta Attacks Rigzone, 1 month ago Unbelievable! Why God will continue to punish Nigeria IPOB Uncova, 2 months ago

PharmaBiz

Dr Reddy's facing tough times but set to overcome with investments in R&D for new drugs

Dr Reddy's Laboratories (DRL), the second largest Indian pharma major with consolidated net sales of Rs. 15,400 crore plus, has set to overcome challenging circumstances with higher investment in research and development, focus on operational ...

PharmaBiz, 2 months ago

Prev | Next